e-Article
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: The EMPEROR-Reduced trial
Document Type
Article
Author
Source
In: European Heart Journal . (European Heart Journal, 7 February 2021, 42(6))
Subject
Language
English
ISSN
15229645
0195668X
0195668X